Evaluating Market Access & Business Opportunities in Asia’s Orphan Drug Industry

In Market Access, Orphan Drugs Live by rachel1 Comment

orphan 2 big

 

Earlier this year at the World Orphan Drug Congress Asia we heard Gary Pasternack, CEO of Asklepion Pharmaceuticals deliver the presentation: Evaluating Market Access & Business Opportunities in Asia’s Orphan Drug Industry.

 

Some points covered in this presentation include:

  • Forecasted Worldwide Orphan Drug Sales 2004-2018
  • Cumulative Orphan Drug Designations
  • Orphan Drug Designations
  • Few Orphan Drugs Reach Asia-Pacific
  • Five Trends Shaping Sales Performance Across the Globe
  • 5 Barriers for Orphan Drugs in Asia Pacific
  • Essential Medicines vs. Orphan Drugs
  • Asia’s Opportunity
  • Evaluating Market Access & Business Opportunities
  • Asia’s Population
  • Asia’s Ability to Pay?
  • Orphan Drug Legal Framework
  • Orphan Drug Financial Framework
  • Orphan Drug Pricing & Reimbursement Framework
  • Orphan Drug Public Awareness
  • Asia’s Trading Partners
  • Awareness of International Organizations
  • Emerging Markets, Emerging Opportunities
  • Partnership

Click here to download this presentation

If this interested you then you may also be interested in attending the World Orphan Drug Congress Asia 2014. Click here to visit the event website for more information >

Comments

  1. Pingback: Orphan Drugs in Asia: What you need to know - Orphan Drugs : Orphan Drugs

Leave a Comment

Current ye@r *